Neuro GASTRo 2017 24 - 26 August 2017 - University College Cork (UCC), Cork, Ireland - ESNM
←
→
Page content transcription
If your browser does not render page correctly, please read the page content below
ESNM 2017 www.neurogastro2017.org © Peter O'Toole / Shutterstock.com Neuro GASTRo 2017 Biennial Meeting of the European Society of Neurogastroenterology and Motility 24 – 26 August 2017 University College Cork (UCC), Cork, Ireland FINAL PRoGRAMME 01
Congress Venue University College Cork College Road Cork T12 YN60, Ireland Main Entrance on the corner of Western Road and Donovan Road www.ucc.ie Host Organisation ESNM – European Society of Neurogastroenterology & Motility c/o Vienna Medical Academy Alser Strasse 4 1090 Vienna, Austria Phone: +43 (0)1 405138331 Fax: +43 (0)1 4078274 Email: info@esnm.eu www.esnm.eu Congress and Exhibition Office CPO HANSER SERVICE Paulsborner Str. 44 14193 Berlin, Germany Phone: +49 (0)30 3006690 Fax: +49 (0)30 3057391 Email: neurogastro2017@cpo-hanser.de www.cpo-hanser.de
ESNM 2017 Table of Contents 04 Welcome Address 32 Overview of Meeting Rooms 05 Committees and Organiser 33 Congress Information 06 Structure of the Scientific Programme 35 General Information 07 Scientific Information – Overview 38 Acknowledgements / List of Exhibitors Scientific Programme by Day 39 Exhibition Plan 10 Thursday, 24 August 2017 12 Friday, 25 August 2017 40 Industry Sponsored Sessions 15 Saturday, 26 August 2017 41 List of Chairpersons and Presenters Poster Presentations / Tours by Day 18 Friday, 25 August 2017 25 Saturday, 26 August 2017 Get the free Congress App for your smartphone Quickly find your way through the most up-to-date congress schedule of scientific sessions. c Quickly find your way through the most up-to-date congress schedule. c Mark your favourite sessions and personalise your experience. c Access vital information around the congress. The NeuroGASTRO 2017 Congress App is powered by GLOBIT GmbH in cooperation with esanum GmbH. 03
ESNM 2017 Welcome Address Welcome to Cork at NeuroGASTRO 2017, the Meeting of the European Society of Neurogastroenterology and Motility (ESNM) in collaboration with the APC Microbiome Institute and University College Cork. We are excited to spend the next days with you to present, share and debate on the latest basic and clinical science and research in the field of Neurogastroenterology and Motility. This is a unique opportunity to present your work, discuss your neu- rogastroenterology research and clinical practice with numerous col- Giovanni Barbara Paul Enck leagues and a distinguished faculty from Europe and around the globe. NeuroGASTRO is a well-established European event that brings together leading experts and emerging young investigators actively involved in neurogastroenterology, digestive motility and functional gastrointes- tinal diseases from Europe and from all around the world to discuss cutting-edge research. The APC Microbiome Institute is recognised as one of the leaders in the field of microbiome science. Cork is the international gateway to Ireland’s Wild Atlantic Way with Cork International Airport serving over 50 international destinations. Cork is the Food Capital of Ireland, home to the birthplace of modern Niall Hyland Gerard Clarke Irish Cuisine at Ballymaloe, the famed English Market and also home to the best artisan food producers in the country. Don’t just take our word for it – as Lonely Planet themselves said ‘Everything good about Ireland can be found in County Cork’. We hope to see you in Cork in 2017. Giovanni Barbara Paul Enck Niall Hyland Gerard Clarke ESNM ESNM ESNM Scientific University College President Treasurer Committe Member Cork, Ireland 04
ESNM 2017 Committees & Organiser Steering Committee Scientific Programme Committee President Chairs Giovanni Barbara, Italy Niall Hyland, Ireland Gerard Clarke, Ireland Treasurer Members Paul Enck, Germany Roberto De Giorgio, Italy David Grundy, United Kingdom Councillors Asbjørn Mohr Drewes, Denmark Fernando Azpiroz, Spain Sabine Roman, France Serhat Bor, Turkey Michael Schemann, Germany Ram Dickman, Israel André Smout, The Netherlands Vasile Drug, Romania Adam Farmer, United Kingdom Niall Hyland, Ireland ESNM Asbjørn Mohr Drewes, Denmark European Society of Beate Niesler, Germany Neurogastroenterology & Motility Luis Novais, Portugal c/o Vienna Medical Academy Daniel Pohl, Switzerland Alser Strasse 4 Sabine Roman, France 1090 Vienna, Austria Edoardo Savarino, Italy Phone: +43 (0)1 405138331 Jordi Serra, Spain Fax: +43 (0)1 4078274 André Smout, The Netherlands Email: info@esnm.eu Jan Tack, Belgium www.esnm.eu Alexander Trukhmanov, Russia affiliated with ESNM Awards A limited number of travel awards are provided to investigators (35 years or younger) who had an abstract accepted for presentation (oral or poster) based on scientific quality of submission. The travel award includes a travel grant of EUR 500 plus a free registration to the NeuroGASTRO congress. Payments will be made in Euro after the congress. Please note that the presenting authors must register and attend the meeting to be eligible for the award. All awards will be delivered during the Closing Ceremony. 05
ESNM 2017 Structure of the Scientific Programme The scientific programme is structured according to days, Posters time and room. All presenters are listed by name and the Authors are invited to present their latest research findings title of their presentation. or important ongoing research as posters; these have been grouped into areas of research by the NeuroGASTRO sci- entific committee. Plenary Lectures The sessions will usually last 60 minutes. They focus on a particular topic and present the very latest data related to it. TANDEM Session The plenary lecture will include an expert speaker who will The ESNM and TANDEM are presenting the Young Investi- first present their research followed by a closing discussion. gator Award supported by Nature Reviews Gastroenterology Hepatology. The award includes a free registration to the congress as well as a monetary grant of EUR 400 each for Symposia the two winning teams of the TANDEM project. These sessions will usually last 90 minutes. Each sympo- sium will be chaired by two experts and will include three speakers who first present their latest research data on a Industry Sponsored Session particular topic followed by a wrap-up discussion. The Industry sponsored session is organised by the industry in consultation with the scientific committee. The session is scheduled for Friday during the congress but outside of Free Presentations the scientific programme. Selected abstract submissions will be presented during free presentations generally lasting 60 minutes. Oral presenters will be allocated 15 minutes for their presentation including time for questions from the audience. CME Accreditation The NeuroGASTRO 2017 Congress in Cork, Ireland, 24 – 26 August 2017 was granted 16 European CME credits (ECMEC) by the European Accreditation Council for Continuing Medical Education (EACCME). 06
ESNM 2017 Scientific Information – Overview Thursday, 24 August 2017 Room a Boole 4 Boole 3 Boole 1 Devere Devere Hall Boole 5 Time d Hall /Bearra 08:00 08:30 PGC-01 – Part 1 The Gut microbi- 09:00 ome and diet in neurogastroenterol- ogy: A guide for the 09:30 clinician 10:00 10:30 Coffee Break in Devere Hall 11:00 PGC-01 – Part 2 The Gut microbi- 07:30 – 18:30 11:30 ome and diet in neurogastroenterol- ESNM General ogy: A guide for the Assembly 12:00 clinician – members only – 12:30 12:30 – 13:25 Opening of the congress and life- registratioin 13:00 time achievement award 10:30 – 19:00 13:30 S-01 S-02 S-03 Dietary interven- Challenges in Neurogastroenter- 14:00 tions including pro- severe digestive ology: Across the biotics, prebiotics disorders lifespan and synbiotics 14:30 exhibition 15:00 Coffee Break in Devere Hall 15:30 FP-01 FP-02 FP-03 Dietary interven- Challenges in Neurogastroenter- 16:00 tions including pro- severe digestive ology: Across the biotics, prebiotics disorders lifespan and synbiotics 16:30 PL-01 17:00 The microbiome as a regulator of the 17:30 brain-gut axis: ... 18:00 18:30 Welcome Reception in the exhibition area Devere Hall 19:00 07
ESNM 2017 Scientific Programme – Overview Friday, 25 August 2017 Room a Boole 4 Boole 3 Boole 1 Devere Boole 5 Aula Time d Hall Maxima 08:00 SS-01 GENIEUR-reloaded 08:30 09:00 S-04 S-05 S-06 Enteric plasticity Food allergies, Treatment of visceral 09:30 intolerances and pain – lessons from FODMAPS pancreatitis 10:00 10:30 p-01 – p-09 poster tours 12:00 – 13:00 Coffee Break in Devere Hall 09:00 – 17:00 11:00 FP-04 FP-05 FP-06 07:00 – 18:30 Enteric plasticity Mixed topic from Treatment 11:30 paper session I of visceral pain 12:00 S-07 12:05 – 13:30 09:00 – 19:00 poster exhibition Hot topics from the 12:30 Rome Foundation research agenda Lunch in Devere Hall registration 13:00 13:30 SA-01 exhibition Industry sponsored 14:00 Symposium 14:30 PL-02 14:30 – 15:25 Translational perspec- 15:00 tives in Neurogastro- enterology 15:30 S-10 S-08 S-09 Satellite Symposium New technologies in Stress and functional 16:00 NEUROGUT clinical neurogastro- gastrointestinal enterology disorders 16:30 17:00 Coffee Break in Devere Hall 17:30 FP-07 FP-08 New technologies in Stress and functional 18:00 clinical neurogastro- gastrointestinal enterology disorders 18:30 19:00 08
ESNM 2017 Scientific Programme – Overview Saturday, 26 August 2017 Room a Boole 4 Boole 3 Boole 1 Devere Boole 5 Aula Time d Hall Maxima 08:00 08:30 09:00 FP-11 S-11 S-12 Mixed topic from Enterochromaffin cells, Biomarkers in irritable 09:30 paper session III endocrine cells and bowel syndrome brush border cells: Role in signalling from p-10 – p-18 poster tours 12:00 – 13:00 poster exhibition 09:00 – 15:30 10:00 the lumen 08:00 – 16:30 10:30 Coffee Break in Devere Hall 09:00 – 16:00 11:00 IGM-01 FP-09 FP-10 Tandem Meeting Enterochromaffin cells, Biomarkers in irritable 11:30 endocrine cells and bowel syndrome brush border cells:... registration 12:00 exhibition 12:30 13:00 Lunch in Devere Hall 13:30 14:00 14:30 PL-03 Vagal neurocircuits in 15:00 neurogastroenterology 15:30 Closing Ceremony and presentation of 16:00 best abstract awards 16:30 Abbreviations Scientific Overview FP Free Presentations PL Plenary Lecture IGM Tandem Meeting S Symposium P Posters SA Industry Sponsored Session PGC Post Graduate Course SS Special Session 09
ESNM 2017 Scientific Programme by Day Thursday, 24 August 2017 PGC-01 Postgraduate Course 004 Fecal microbial transplantation. Current and future indications 08:30 – 08:40 Boole Lecture Theatre 1 Gianluca Ianiro, Italy The Gut microbiome and diet in neurogastroenterology – a guide for the clinician Chairs: Eamonn Quigley, USA Magnus Simrén, Sweden Opening Ceremony 001 Welcome and opening comments 12:30 – 13:25 Boole Lecture Theatre 4 Eamonn Quigley, USA Opening of the congress Giovanni Barbara, Italy Chairs: Paul Enck, Germany Giovanni Barbara, Italy 08:40 – 09:30 Niall Hyland, Ireland Characterising the Gut microbiome in clinical practice 12:30 – 12:45 001 Techniques used to characterize the gut micro- Welcome address biota: A guide for the clinician Paul Cotter, Ireland 12:45 – 12:55 Presentation of the lifetime achievement award 002 Influence of diet and exercise on the gut micro- biome 12:55 – 13:25 Orla O‘Sullivan, Ireland Opening Lecture Developments in clinical neurogastroenterology 09:30 – 10:30 André Smout, The Netherlands Microbiome profiling as a diagnostic or prognostic bio- marker of disease 001 Challenges in using gut microbiota analysis as S-01 Symposium a diagnostic/prognostic tool in diseases and dis- orders 13:30 – 15:00 Boole Lecture Theatre 4 Marcus Claesson, Ireland Dietary interventions including probiotics, prebiotics and synbiotics 002 Microbiota signatures and gastrointestinal symp- Chairs: Siobhain O´Mahony, Ireland toms Fernando Azpiroz, Spain Magnus Simrén, Sweden 003 The gut microbiome and IBS: The GENIEUR 001 Probiotic effects on gut physiology approach to clinical phenotyping Vassilia Théodorou, France Mirjana Rajilic-Stojanovic, Serbia 002 Pharmabiotic manipulation of the microbiota in gastrointestinal disorders: A clinical perspective Eamonn Quigley, USA 003 Early life nutritional bioactives in neurogastro- 10:30 – 11:00 Coffee Break in Devere Hall enterology Sharon Donovan, USA 11:00 – 12:20 Considerations in choosing microbiome targeted therapies S-02 Symposium 001 Microbiome-gut-brain axis; clinical implications 13:30 – 15:00 Boole Lecture Theatre 3 for neurogastroenterology Timothy Dinan, Ireland Challenges in severe digestive disorders Chairs: Jan Tack, Belgium 002 Dietary interventions for functional bowel symp- Nathalie Rommel, Belgium toms; impact and relevance of diet-microbiome interactions 001 Oesophageal achalasia Hans Törnblom, Sweden Guy Boeckxstaens, Belgium 003 Prebiotics, probiotics and synbiotics in neuro- 002 Gastroparesis gastroenterology – what are the outcomes? Vincenzo Stanghellini, Italy Alex Ford, United Kingdom 003 Severe intestinal dysfunctions Roberto De Giorgio, Italy 10
ESNM 2017 Scientific Programme by Day Thursday, 24 August 2017 S-03 Symposium 002 Delivery of neural stem cells to the gut using mesenterial perfusion 13:30 – 15:00 Boole Lecture Theatre 1 Lisa Marx, Germany Neurogastroenterology: Across the lifespan 003 Effects of intestinal alkaline phosphatase on in- Chairs: Michel Neunlist, France testinal permeability and bacterial translocation Agata Mulak, Poland in an experimental model for sepsis 001 The Gut microbiota and healthy aging Philip Plaeke, Belgium Paul O‘Toole, Ireland 004 Inflammatory state and phenotypic switch of 002 Ageing and neurogastroenterology human smooth muscle in diverticulosis and Gareth Sanger, United Kingdom complicated diverticular disease Carola Severi, Italy 003 Paediatric neurogastroenterology: A clinical perspective Nikhil Thapar, United Kingdom FP-03 Free Presentation 15:30 – 16:30 Boole Lecture Theatre 1 Neurogastroenterology: Across the lifespan 15:00 – 15:30 Coffee Break in Devere Hall Chairs: Gareth Sanger, United Kingdom Nikhil Thapar, United Kingdom 001 Brain-microbiome-behavior associations follow- FP-01 Free Presentation ing early adversity: A proof of concept study across development 15:30 – 16:30 Boole Lecture Theatre 4 Bridget Callaghan, USA Dietary interventions including probiotics, prebiotics 002 Development of coordinated electrical activity and synbiotics in the human foetal enteric nervous system Chairs: Vassilia Théodorou, France Conor McCann, United Kingdom Sharon Donovan, USA 003 Infant faecal microbiome diversity and behav- 001 Bifidobacterium Breve NCFB 2258 stimulates ioural outcomes at age two vagal nerve firing across an intact colonic barrier Amy Loughman, Australia Dervla O‘Malley, Ireland 004 Development of functional innervation of the 002 Protease activity and tryptase expression is in- gastrointestinal mucosa creased in a post-inflammatory rat model for Marlene Hao, Australia visceral hypersensitivity Hannah Ceuleers, Belgium 003 Influence of the herbal extract combination STW 5 on the human intestinal microbiota in vitro PL-01 Plenary Lecture Heba Abdel-Aziz, Germany 16:45 – 17:45 Boole Lecture Theatre 4 004 Disruption of colonic microbiome and circulating The microbiome as a regulator of the brain-gut axis: metabolome in antibiotic-treated mice From stress to visceral pain Angela Jacan, Austria Chair: Timothy Dinan, Ireland 001 The microbiome as a regulator of the brain-gut axis: From stress to visceral pain FP-02 Free Presentation John F. Cryan, Ireland 15:30 – 16:30 Boole Lecture Theatre 3 Challenges in severe digestive disorders Chairs: Guy Boeckxstaens, Belgium Welcome Reception Roberto De Giorgio, Italy 18:00 – 19:00 Devere Hall 001 Novel mutations in neurogenic chronic intestinal pseudo-obstruction identified by high-through- put sequencing Francesca Bianco, Italy 11
ESNM 2017 Scientific Programme by Day Friday, 25 August 2017 SS-01 SPECIAL SESSION S-06 Symposium 08:00 – 09:00 Boole Lecture Theatre 1 09:00 – 10:30 Boole Lecture Theatre 1 GENIEUR-reloaded Treatment of visceral pain – lessons from pancreatitis Chairs: Beate Niesler, Germany Chairs: André Smout, The Netherlands Magnus Simrén, Sweden Adam Farmer, United Kingdom 001 Up-date GENIEUR activities 001 Basic mechanisms Beate Niesler, Germany; Magnus Simrén, Sweden Ihsan Ekin Demir, Germany 002 LINK award project ‘HELP EU in IBS’ 002 Translational aspects – central sensitization Beate Niesler, Germany; Magnus Simrén, Sweden Søren Schou Olesen, Denmark Lobbying for IBS research 003 Algorithm based personalized treatment Beate Niesler, Germany; Magnus Simrén, Sweden Asbjørn M. Drewes, Denmark 003 AOB Beate Niesler, Germany; Magnus Simrén, Sweden 10:30 – 11:00 Coffee Break in Devere Hall S-04 Symposium 09:00 – 10:30 Boole Lecture Theatre 4 Enteric plasticity FP-04 Free Presentation Chairs: Nick Spencer, Australia 11:00 – 12:00 Boole Lecture Theatre 4 Kirsteen Browning, USA Enteric plasticity 001 Enteric neurotransmission Chairs: Michael Schemann, Germany Michael Schemann, Germany Andreas Friebe, Germany 002 Central nervous system diseases and the gas- 001 Role of semaphorin 3A in the postnatal devel- trointestinal tract opment of the enteric nervous system Michel Neunlist, France Jacques Gonzales, France 003 Interstitial cells of cajal 002 Small intestine neuromuscular dysfunctions in Andreas Friebe, Germany Toll-like receptor 4-null mice: Role of enteric glia Silvia Cerantola, Italy 003 ANO1 knockdown causes disrupted antral pace- maker activity, discordinated popagating antral S-05 Symposium contractions and delayed gastric emptying 09:00 – 10:30 Boole Lecture Theatre 3 Sean Ward, USA Food allergies, intolerances and FODMAPS 004 Single cell photo-stimulation elicits neuron- Chairs: Hans Törnblom, Sweden to-glia communication in the enteric nervous Magnus Simrén, Sweden system Werend Boesmans, Belgium 001 Food allergies and eosinophilic esophagitis Sabine Roman, France 002 Role of FODMAPS Jessica Biesiekierski, Belgium 003 Gluten and wheat sensitivity Umberto Volta, Italy 12
ESNM 2017 Scientific Programme by Day Friday, 25 August 2017 FP-05 Free Presentation 11:00 – 12:00 Boole Lecture Theatre 3 12:00 – 14:30 Lunch Break in Devere Hall Mixed topic free paper session I Poster Tours in Aula Maxima Chairs: Jessica Biesiekierski, Belgium Umberto Volta, Italy 001 Proton pump inhibitor therapy improves esoph- S-07 Symposium ageal symptoms by restoring a normal esoph- 12:05 – 13:30 Boole Lecture Theatre 4 ageal peristalsis in patients with proton pump inhibitor-response esophageal eosinophilia Hot topics from the Rome Foundation research agenda Marco della Coletta, Italy Chairs: Jan Tack, Belgium Giovanni Barbara, Italy 002 Actions of bis-(p-hydroxyphenyl)-pyridyl-2- methane – the active metabolite of the laxative 001 The Rome Foundation: Programs and activities bisacodyl – on human intestine in vitro Jan Tack, Belgium Dagmar Krueger, Germany 002 Global epidemiological study of the FGIDs 003 Low-dose penicillin exposure in adolescent mice Ami D. Sperber, Israel has long-term, sex-dependent consequences on 003 Brain imaging and FGID behaviour and physiology Lukas van Oudenhove, Belgium Karen-Anne McVey Neufeld, Canada 004 Rome IV: New diagnostic criteria for functional 004 Corticotropin-releasing factor in activated esophageal disorders mucosal eosinophils is associated with clini- Qasim Aziz, United Kingdom cal severity in diarrhea-prone Irritable Bowel Syndrome (IBS) Eloisa Salvo Romero, Spain SA-01 Industry sponsored session 13:30 – 14:30 Boole Lecture Theatre 3 FP-06 Free Presentation see page 40 11:00 – 12:00 Boole Lecture Theatre 1 Treatment of visceral pain Chairs: Asbjørn M. Drewes, Denmark PL-02 Plenary Lecture Ihsan Ekin Demir, Germany 14:30 – 15:25 Boole Lecture Theatre 4 001 Faecal supernatants from diarrhoea predominant Translational perspectives in neurogastroenterology Irritable Bowel Syndrome (IBS) patients disrupt Chair: Eamonn Quigley, USA colonic epithelial barrier function and directly activate colo-rectal afferent nerves 001 Translational perspectives in neurogastroen- Hannah Wardill, Australia terology Jan Tack, Belgium 002 Abdominal pain in hypermobile Ehlers Danlos Syndrome (hEDS) may be associated with pro- liferation of colonic nociceptive nerve endings Rubina Aktar, United Kingdom S-10 Symposium 003 The histamine receptor H4 is functionally ex- 15:30 – 17:00 Boole Lecture Theatre 4 pressed on murine colonic sensory neurons and Satellite Symposium NEUROGUT contributes to chronic visceral hypersensitivity Chairs: Paul Enck, Germany Annemie Deiteren, Australia Giovanni Barbara, Italy 004 Involvement of the serotonin pathway in ileal 001 The NEUROGUT Initial Training Network (ITN) neuromotor dysfunction associated with TLR2 2014 – 2018 – Introduction and TLR4 inhibition in juvenile mice Paul Enck, Germany Ilaria Marsilio, Italy 002 NEUROGUT progress, as seen from a PI David Grundy, United Kingdom 13
ESNM 2017 Scientific Programme by Day Friday, 25 August 2017 003 NEUROGUT Training, seen by a trainee FP-07 Free Presentation Annikka Polster, Sweden 17:30 – 18:30 Boole Lecture Theatre 3 004 NEUROGUT Training Network, an external ad- New technologies in clinical neurogastroenterology visor´s perspective Chairs: Carolina Malagelada, Spain Jackie Wood, USA Serhat Bor, Turkey 001 Optogenetic induction of propagating colonic motor complexes and propulsion of fecal content S-08 Symposium induced by light 15:30 – 17:00 Boole Lecture Theatre 3 Nick Spencer, Australia New technologies in clinical neurogastroenterology 002 Assessment of Duodeno/Jejunal baseline im- Chairs: Sabine Roman, France pedance as a surrogate of evaluation of mucosal Martin Buckley, Ireland integrity in patients with functional dyspepsia: Importance of timing of measurement relative 001 What is the future of impedance planimetry? to phase III of the MMC Hans Gregersen, Hong Kong SAR, China Kenichiro Nakagawa, United Kingdom 002 Adjunction of impedance measurements to es- 003 A comparison of the efficacy and safety of two ophageal manometry: Is it really better than dosing regimens, 2 and 5 times per week, of an manometry alone? intraluminal vibrating capsule in the manage- Nathalie Rommel, Belgium ment of chronic idiopathic constipation 003 Luminal imaging Eamonn Quigley, USA Carolina Malagelada, Spain 004 MRI detection and histological localization of transplanted neural crest derived stem cells (NCSCs) labeled with superparamagnetic nan- oparticles in future perspectives for cell therapy S-09 Symposium of Hirschsprung‘s disease 15:30 – 17:00 Boole Lecture Theatre 1 Jasmin Clasohm, Germany Stress and functional gastrointestinal disorders Chairs: Niall Hyland, Ireland Serhat Bor, Turkey FP-08 Free Presentation 001 Genetics and epigenetics of the stress response 17:30 – 18:30 Boole Lecture Theatre 1 Rene van den Wijngaard, The Netherlands Mixed topic free paper session II 002 Brain imaging and stress Chairs: Sigrid Elsenbruch, Germany Sigrid Elsenbruch, Germany Rene van den Wijngaard, The Netherlands 003 Psychological therapies in functional bowel dis- 001 Satiety is modulated by the intraluminal colonic orders volume in healthy subjects Gabriele Moser, Austria Noemi Caballero de Garcia, Spain 002 Duodenal acidification impairs duodenal integ- rity and activates the duodenogastric reflex, independently from mast cell activation 17:00 – 17:30 Coffee Break in Devere Hall Tim Vanuytsel, Belgium 003 Dopamine transporter genetic reduction affects small-bowel neuromuscular contractility in mice Valentina Caputi, Italy 004 Altered expression of the homeobox transcrip- tion factor Phox2b in the myenteric plexus of patients with diverticular disease François Cossais, Germany 14
ESNM 2017 Scientific Programme by Day Saturday, 26 August 2017 FP-11 Free Presentation S-12 Symposium 09:00 – 10:30 Boole Lecture Theatre 4 09:00 – 10:30 Boole Lecture Theatre 1 Mixed topic free paper sessions III Biomarkers in irritable bowel syndrome Chairs: Luis Novais, Portugal Chairs: Gerard Clarke, Ireland Goran Hauser, Croatia Niall Hyland, Ireland 001 Serum from patients with Crohn´s Disease ac- 001 GENIEUR: Genes in IBS tivates guinea pig enteric neurons Beate Niesler, Germany Maria Lazarou, Germany 002 Microbiome and IBS 002 Colorectal cancer cells induce neurogenesis in Mirjana Rajilic-Stojanovic, Serbia the enteric nervous system of the tumor mi- 003 Clinical biomarkers in irritable bowel syndrome croenvironment via a NGF-dependent pathway Magnus Simrén, Sweden Farouk Drissi, France 003 Neurodegeneration of the ENS might be pre- vented by treatment with nanomodified anti- oxidants Karl-Herbert Schäfer, Germany 10:30 – 11:00 Coffee Break in Devere Hall 004 Electrophysiological changes and mucosal per- meability in phenotypes of gastroesophageal reflux disease Pelin Ergun, Turkey IGM-01 TANDEM Meeting 11:00 – 12:00 Boole Lecture Theatre 4 TANDEM meeting Chairs: Paul Enck, Germany S-11 Symposium Miriam Goebel-Stengel, Germany 09:00 – 10:30 Boole Lecture Theatre 3 Enterochromaffin cells, endocrine cells and brush bor- der cells: Role in signalling from the lumen Chairs: Roberto De Giorgio, Italy FP-09 Free Presentation Siobhain O´Mahony, Ireland 11:00 – 12:00 Boole Lecture Theatre 3 001 Luminal nutrient transport and signalling Enterochromaffin cells, endocrine cells and brush bor- Inge Depoortere, Belgium der cells: Role in signalling from the lumen Chairs: Fiona Gribble, United Kingdom 002 Gut-derived hormones and the brain-gut axis Catia Sternini, USA Fiona Gribble, United Kingdom 003 ECC cells as a site of taste for luminal bacteria 001 Intrauterine growth retardation in rats alters Catia Sternini, USA palmitoleate sensing by duodenal entero-en- docrine cells, leading to increased-intestinal permeability Marieme Ndjim, France 002 Long-term effects of Roux-en-Y gastric bypass surgery on colonic nutrient-sensing receptors and enteroendocrine cells Madusha Peiris, United Kingdom 003 Multiple nutrient stimulation enhances enteroen- docrine cell responses in human and mouse colon Madusha Peiris, United Kingdom 004 L-cells are key to cross-barrier signalling to the host peripheral nervous system by a GLP-1-se- creting putative probiotic Eilish Brosnan, Ireland 15
ESNM 2017 Scientific Programme by Day Saturday, 26 August 2017 FP-10 FREE PRESENTATIoN 11:00 – 12:00 Boole Lecture Theatre 1 Biomarkers in irritable bowel syndrome Chairs: Mirjana Rajilic-Stojanovic, Serbia Visit the Poster Daniel Pohl, Switzerland Exhibition 001 Granins are linked to bacterial richness, innate immunity, markers for intestinal permeability in Aula Maxima and symptom severity IBS patients Johanna Sundin, Sweden 002 Insular brain metabolites are related to somatic on Friday, 25 August 2017 symptom burden and cognitive coping in Irrita- from 09:00 – 17:00 and ble Bowel Syndrome (IBS) Adriane Icenhour, Sweden on Saturday, 26 August 2017 003 Magnetic resonance imaging assessed small bowel dysmotility and its relationship with pa- from 09:00 – 15:30 tient reported symptoms: An exploration of au- tomated vs subjective assessment techniques Ruaridh Gollifer, United Kingdom 004 Lactobacillus rhamnosus GG soluble mediators ameliorate visceral hypersensitivity and changes in spinal cord gene expression induced by early life stress Karen-Anne McVey Neufeld, Canada 12:00 – 14:30 Lunch Break in Devere Hall Poster Tours in Aula Maxima PL-03 PLENARy LECTuRE 14:30 – 15:30 Boole Lecture Theatre 4 Vagal neurocircuits in neurogastroenterology Chair: David Grundy, United Kingdom 001 Vagal neurocircuits in neurogastroenterology Kirsteen Browning, USA CLoSING CEREMoNy 15:30 – 16:30 Boole Lecture Theatre 4 Closing Ceremony and presentation of best abstract awards 16
FNM 2018 3rd Meeting of the Federation of Neurogastroenterology and Motility and Postgraduate Course on Gastrointestinal Motility 29 August – 1 September 2018 RAI Convention Center Amsterdam, the Netherlands SAVE TH E DATE vichie81 @ – fotolia.com Hosting Society Associated Partners ESNM – European Society of ANGMA – Australasian Neurogastro- Neurogastroenterology and Motility enterology and Motility Association SLNG – Sociedad Latinoamericana Co-organisers de Neurogastroenterología ANMS – American Neurogastro- enterology and Motility Society Congress and Exhibition office ANMA – Asian Neurogastro- enterology and Motility Association CPO HANSER SERVICE Zum Ehrenhain 34 22885 Barsbüttel // Germany Phone: +49 – 40 – 670 88 20 Fax: +49 – 40 – 670 32 83 Email: fnm2018@cpo-hanser.de www.fnm2018.org
ESNM 2017 Poster Presentations / Tours by Day Friday, 25 August 2017 P-01 Poster Presentation 003 Functional compensation of gastro intestinal motility indicates enteric plasticity in an early 12:00 – 13:00 Aula Maxima onset model of Alzheimer‘s Disease Dietary interventions including probiotics, prebiotics Jasmin Clasohm, Germany and synbiotics S. Ull-Sopha, N. Stoye, K. Endres, H. Rabe, K.-H. Discussant: Schäfer Sharon Donovan, USA Abstracts 001 – 005 004 nELAV mRNA-binding protein, HuC/D alteration in adolescent mice small intestine after antibi- 001 Sheep and cow milk and yogurt drinks influence otic treatment-induced dysbiosis gastrointestinal transit in a rat model Cristina Giaroni, Italy Julie Dalziel, New Zealand M. Bistoletti, V. Caputi, F. Fagiani, V. Filpa, I. C. Berry, G. Smolenski, S. Haines, L. Day Marsilio, S. Cerantola, F. Crema, A. Baj, A. Pas- 002 Obesity-induced alterations in colonic transit cale, M. C. Giron are normalized by dietary prebiotic supplemen- 005 Glial PGE2 production induced by inflammation tation: role of gut microbiota regulates glial response to ATP Anna Golubeva, Ireland Malvyne Rolli-Derkinderen, France D. Kandil, S. Arboleya, A. Burokas, K. Murphy, C. T. Rousseau, E. Baudu, C. Pochard, M. Neunlist Stanton, N. Hyland, G. Clarke, T. Dinan, H. Schell- ekens, J. Cryan 006 Pitfalls in the interpretation of high-resolution anorectal manometry 003 Diurnal regulation of colonic motility by short- Eva Sandell, Sweden chain fatty acids E. Lindgren, L. Flodqvist, G. Lindberg Anneleen Segers, Belgium L. Desmet, T. Thijs, K. Verbeke, J. Tack, I. Depoortere 004 High fat diet-induced depression-like behaviour P-03 Poster Presentation in mice: Roles of intestinal microbiome, neuro- peptide Y, and brain metabolome 12:00 – 13:00 Aula Maxima Ahmed M. Hassan, Austria Neurogastroenterology: Across the lifespan G. Mancano, K. Kashofer, E. E. Fröhlich, A. Matak, Discussants: R. Mayerhofer, F. Reichmann, M. Olivares, A. M. Gareth Sanger, United Kingdom Abstracts 001 – 005 Neyrinck, N. M. Delzenne, S. P. Claus, P. Holzer Agata Mulak, Poland Abstracts 006 – 011 Nikhil Thapar, United Kingdom Abstracts 012 – 016 005 Effects of different bacterial strains in the form of the Probiotics Symbioflor® on the enteric nerv- 001 Motor function of digestive tract at children ous system and gut motility with the obesity Maximilian Weyland, Germany Ekaterina Aleshina, Russia D. Grundmann, L. Marx, M. Martin, M. Hau, K.-H. A. Khavkin, V. Novikova, S. Shoferova, M. Komis- Schäfer sarova, L. Vorontsova 002 Extracellular matrix composition in the enteric P-02 Poster Presentation nervous system of mice Cristiano Bacarin, Brazil 12:00 – 13:00 Aula Maxima P. Da Silva Watanabe, A. Franciosi, J. D.L. Mendes, Enteric plasticity R. Aktar, L. A. Blackshaw, E. J.A. Araujo Discussant: Michael Schemann, Germany Abstracts 001 - 006 003 Role of NO-GC on long distance contractions in the murine colon 001 Expression and neurochemical identity of sen- Katharina Beck, Germany sory fibres is altered in Inflammatory Bowel B. Voussen, A. Vincent, D. Groneberg, S. P. Parsons, Disease (IBD) J. D. Huizinga, A. Friebe Madusha Peiris, United Kingdom 004 Distribution of RAD21 immunoreactivity in R. Kaur Kahlon, R. Aktar, S. Raynel, L. A. Blackshaw mouse and human gut neurons 002 Enteric glial cells reaction to inflammation is Francesca Bianco, Italy lost in Crohn‘s Disease S. J. Gibbons, E. Bonora, S. T. Eisenman, P. Claven- Malvyne Rolli-Derkinderen, France zani, R. De Giorgio, G. Farrugia C. Pochard, T. Clairembault, N. Cenac, E. Duchalais, A. B. Bourreille, M. Neunlist 18
ESNM 2017 Poster Presentations / Tours by Day Friday, 25 August 2017 005 Patients with all types of congenital anorectal 014 Responsibility of patients towards the manage- malformation seem to have fecal continence ment of their Irritable Bowel Syndrome (IBS): reflexes A qualitative study Jara Jonker, The Netherlands Tudor-Stefan Rotaru, Romania V. den Hollander, M. Trzpis, P. Broens V.-L. Drug 006 Degree of colonic cholinergic innervation de- 015 Trivalent chromium suppresses gastrointestinal termines bacterial translocation in pediatric motility and secretion in experimentally altered Morbus Hirschsprung patients gut homeostasis in laboratory rodents Simone Keck, Switzerland Olugbenga Odukanmi, Nigeria S. Holland-Cunz A. Salami, K. Ogunwole, O. Busari, T. Homma, S. Olaleye 007 Neuromuscular changes in asymptomatic diver- ticulosis and diverticular disease 016 Innovative technology solutions to explore ef- Christina Lange, Germany fects of the microbiome on intestine and brain M. Barrenschee, F. Cossais, I. Hohmeier, M. Ebsen, I. pathophysiology Vogel, J.-H. Egberts, T. Becker, M. Böttner, T. Wedel Roisin Owens, France 008 The herbal medicine STW 5 is efficacious in targeting dyspeptic symptoms in all ages: P-04 Poster Presentation A meta-analysis of randomized controlled trials Olaf Kelber, Germany 12:00 – 13:00 Aula Maxima J. Müller, B. R. Vinson, C. Fink, H. Abdel-Aziz, M. New technologies in clinical neurogastroenterology Storr, K. Kraft, K. Nieber Discussants: 009 Investigation of the brain gut axis in the rAAV-al- Sabine Roman, France Abstracts 001 – 005 pha-synuclein PD model: Reveals enteric nerv- Martin Buckley, Ireland Abstracts 006 – 010 ous system pathology and alterations in the gut Hans Gregersen, China Abstracts 011 – 015 microbiome Nathalia Rommel, Belgium Abstracts 016 – 020 Sarah O‘Donovan, Ireland E. K. Crowley, J. Browne, O. O‘Sullivan, O. O‘Leary, 001 Dynamic MRI for bowel motility imaging: How S. Timmons, Y. M. Nolan, P. O‘Toole, D. J. Clarke, fast and how long? N. Hyland, S. Joyce, A. M. Sullivan, C. O‘Neill C.S. de Jonge, The Netherlands R. Gollifer, A. J. Nederveen, D. Atkinson, S. A. Tay- 010 Depressive symptoms during pregnancy disrupt lor, J. Stoker, A. Menys gut microbiome dynamics during critical prena- tal and postnatal time windows 002 Spectral bowel motility assessment using dy- Katie Togher, Ireland namic tagged MRI A. Khashan, L. Kenny, C. Stanton, I. Carafa, K. Mur- C.S. de Jonge, The Netherlands phy, G. O‘Keeffe, A. Ryan, J. F. Cryan, T. Dinan, G. A. M. Sprengers, A. J. Nederveen, J. Stoker Clarke 003 Volume vs. caloric stimulation of small bowel 011 Effects of nitric oxide on small intestinal motility motility in healthy controls Barbara Voussen, Germany C.S. de Jonge, The Netherlands K. Beck, N. Mauro, J. Keppler, D. Groneberg, A. Friebe A. Menys, K. L. van Rijn, A. J. Nederveen, J. Stoker 012 The cells and conductance mediating cholinergic 004 Ultrasound and wireless motility capsule find- neurotransmission in the stomach ings in patients with Familial GUCY2C diarrhea Tae-Sik Sung, USA syndrome S.-J. Hwang, S.-D. Koh, Y. Bayguinov, P. Blair, J. Odd Helge Gilja, Norway Rock, T. Webb, L. O‘Kane, K. Sanders, S. Ward H. von Volkmann, I. Brønstad, D. A. Sangnes, K. Nylund, R. Tronstad, T. Hausken, G. Dimcevski, T. 013 The influence of calorie restriction on gut mi- Fiskerstrand crobiota in long-living Ames dwarf mice Denise Wiesenborn, Germany 005 Fecobionics: A novel integrated bionics test of A. Schneider, B. Victoria, L. Spinel, D. Grundmann, anorectal function E. Galvez, T. Strowig, M. Masternak, K.-H. Schäfer Hans Gregersen, Hong Kong SAR, China 006 Standardizing parameters of high resolution duodenojejunal manometry in healthy controls William Hasler, USA J. Baker, J. Dickens, M. Koenigsknecht, A. Fioritto, K. Shedden, G. Amidon, D. Sun 19
ESNM 2017 Poster Presentations / Tours by Day Friday, 25 August 2017 007 In vivo assessment of foods that stimulate in- 017 Digestive functional scintigraphy for digestive testinal secretions using magnetic resonance autonomic neuropathy diagnosis: About a case imaging: Implications for dietary advice in ile- Nesrine Robaine, France ostomy care J. M. Senard, L. Sailler, I. Berry, G. Victor Victoria Wilkinson-Smith, United Kingdom 018 Gastric emptying patterns in diabetic patients G. Major, L. Ashleigh, K. Murray, C. Hoad, L. Mar- with functional digestive symptoms: First results ciani, P. Gowland, R. Spiller in 45 patients 008 Gastrointestinal peptides during chronic gastric Nesrine Robaine, France electrical stimulation in patients with intractable O. Lairez, P. Pascal, I. Berry, G. Victor vomiting 019 Per oral endoscopic myotomy for the manage- Mathieu Meleine, France ment of pediatric achalasia C. Melchior, P. Prinz, A. Penfornis, B. Coffin, A. Tsili Zangen, Israel Stengel, P. Ducrotte, G. Gourcerol 020 Higher baseline cardiac vagal tone implicates 009 Morpho-functional evaluation of the gut in cystic a subcortical functional brain network during fibrosis acute oesophageal pain Carolina Malagelada, Spain James Ruffle, United Kingdom A. Bendezu, X. Molero, D. Sihuay, A. Nieto, X. Me- S. Coen, V. Giampietro, S. Williams, A. Farmer, rino, A. Accarino, J.-R. Malagelada, F. Azpiroz Q. Aziz 010 A case for developing a preventative swallow health maintenance program in the elderly P-05 Poster Presentation Dilpesh Agrawal, USA M. Kern, F. Edeani, P. Sanvanson, R. Shaker 12:00 – 13:00 Aula Maxima 011 Rehabilitation of a heterogeneous group of dys- Biomarkers in irritable bowel syndrome/ treatment of phagic patients by a novel exercise technique visceral pain of swallowing against laryngeal restriction Discussants: Dilpesh Agrawal, USA Gerard Clarke, Ireland Abstracts 001 – 006 M. Kern, F. Edeani, P. Sanvanson, R. Shaker Magnus Simrén, Sweden Abstracts 007 – 013 012 The diagnostic value of esophageal mucosal and 001 Longitudinal analysis of IBS patients reveals baseline impedance measurements in patients that acquired immune responses are inhibited with gastroesophageal reflux disease in symptom flare vs. symptom free Sezgi Kipcak, Turkey Patrick Hughes, Australia P. Ergun, S. Bor C. Mavrangelos, M. Campaniello, J. Andrews, P. 013 Characterization of GERD patients using pres- Bampton sure-flow analysis 002 A functional SNP of the serotonin transporter Ans Pauwels, Belgium gene promoter is associated with IBS C. Scheerens, T. Omari, J. Tack, N. Rommel Beate Niesler, Germany 014 Interobserver and intraobserver agreement S. Mohr, N. Hattensperger, C. Martinez, L. Houghton, in classification of defaecatory disorders on S. Schmitteckert, M. Goebel-Stengel, M. Kabisch, C. high-resolution anorectal manometry Hammer, D. Knab, I. Vulic, M. D‘Amato, T. Zheng, Abhishek Sadalage, India H. Mönnikes, S. Berens, F. Kraus, V. Andresen, T. A. Shukla, D. Agrawal, D. Gupta, P. Abraham, M. Frieling, J. Keller, C. Pehl, C. Thöringer, G. Clarke, Meshram, S. Bhatia P. J. Kennedy, J. F. Cryan, T. G. Dinan, E. Quigley, R. Spiller, C. Beltrán, W. Herzog, G. Sayuk, E. A. Mayer, 015 Post-reflux swallow-induced peristaltic wave M. Gazouli, L. Kapur-Pojskic, M. Bustamante, X. index and mean nocturnal baseline impedance Estivill, K. Rabionet, G. Boeckxstaens, M. Wouters, predict heartburn response to proton pump in- M. Simrén, G. A. Rappold, M. Vicario, R. Schäfert, hibitors better than acid exposure time in GERD J. Lorenzo-Bermejo, J. Santos, B. Niesler Edoardo Savarino, Italy M. Frazzoni, N. de Bortoli, S. Tolone, V. Savarino, 003 Heart rate variability characteristics of patients L. Frazzoni with Irritable Bowel Syndrome (IBS) and asso- ciation with symptoms 016 The role of biofeedback therapy in functional Annikka Polster, Sweden disorders P. Friberg, B. Le Nevé, H. Törnblom, M. Simren Oksana Fomenko, Russia A. Y. Titov, S. Belousova, D. Egorova 20
ESNM 2017 Poster Presentations / Tours by Day Friday, 25 August 2017 004 IBS subgroups based on combination of GI and 013 Identification of an analgesic lipopeptide pro- non-GI symptoms in a general population study duced by the probiotic Escherichia coli strain Annikka Polster, Sweden Nissle 1917: Role in visceral hypersensitivity H. Törnblom, O. Palsson, W. Whitehead, M. Simren Julien Pujo, France 005 IBS brain signature: Cerebral microstructure in Irritable Bowel Syndrome (IBS) Eivind Valestrand, Norway P-06 Poster Presentation T. Hausken, A. Lundervold 12:00 – 13:00 Aula Maxima 006 IBS brain signature: Cortical thickness in the Challenges in severe digestive disorders salience network Discussant: Eivind Valestrand, Norway Roberto De Giorgio, Italy Abstracts 001 – 007 T. Hausken, A. Lundervold 001 Correlation between symptoms, quality of life 007 Serum proteomics in African American females and gastric empting among dyspectic patients with IBS: A pilot investigation Guillaume Gourcerol, France Kristen Weaver, USA M. Courde, C. Melchior, A. M. Leroi, P. Ducrotté G. D.´Eramo Melkus, J. Fletcher, W. A. Henderson 002 Prostacyclin reverses colitis through the down 008 miRNA-16 and miR-103 impact 5-HT4 receptor regulation of intestinal epithelial permeability signalling and correlate with symptom profile Camille Pochard, France in Irritable Bowel Syndrome (IBS) P. Aubert, C. Gesret, J. Bregeon, N. Cenac, A. B. Stefanie Schmitteckert, Germany Bourreille, G. Meurette, M. Neunlist, M. Rolli Der- C. Wohlfarth, J. D. Härtle, L. Houghton, H. Dweep, kinderen M. Fortea, A. Ghazaleh, A. Braun, T. Mederer, P. Sarina, P. P. Becker, C. Fischer, M. Granzow, H. 003 Inflammatory and oxidative impairment of antral Mönnikes, E. A. Mayer, G. Sayuk, G. Boeckxstaens, motility in obese patients M. Wouters, M. Simrén, G. Lindberg, B. Ohlsson, P. Annunziata Scirocco, Italy T. Schmidt, A. Dlugosz, L. Agreus, A. Andreasson, L. Pallotta, M. Carabotti, G. Silecchia, A. Ignazzi, M. D‘Amato, B. Burwinkel, J. Lorenzo, R. Röth, F. P. Chirletti, A. Cicenia, M. A. Maselli, E. Corazziari, Lastischka, M. Vicario, M. Metzger, J. Santos, G. A. C. Severi Rappold, C. Martinez, B. Niesler 004 Influence of nitizinon on the performance of 009 Comparative expression profiling in rectal bi- mineralexchange in children with type 1 tyros- opsies of giardia-induced post-infectious IBS: inemia A pilot study Galina Volynets, Russia Beate Niesler, Germany A. Khavkin, A. Nikitin, G. Volynets, T. Skvortsova, C. Martinez, C. Thöni, C. Wohlfarth, K. Hanevik, T. Bushueva M. Granzow, F. Lasitschka, V. Dizdar, T. Hausken, 005 Dynamics of liver dysfunction in children with N. Langeland hereditary tyrosineemia type 1 on the back- 010 Imaging mast cells by confocal microscopy ground of pathogenetic therapy without fluorescent staining for the diagnosis Galina Volynets, Russia of Irritable Bowel Syndrome (IBS) A. Nikitin, T. Skvortsova, A. Khavkin, T. Bushueva, Kang-Nyeong Lee, Republic of Korea A. Nikitin, O. Komarova I.-K. Sung, O.-Y. Lee, J.-H. Kim, E.-J. Kim, H.-Y. Lee, 006 Peripheral and central nervous system defects J.-Y. Lee are associated with altered neuronal projections 011 Global metabolite profiling of multiple sample and early neonatal lethality in a mouse model types to identify markers for Irritable Bowel of Goldberg-Shprintzen megacolon syndrome Syndrome (IBS) Lincon Stamp, Australia Nicole Roy, New Zealand C. Hirst, S. McKeown, A. Bergner, H. Young K. Fraser, H. Noh, W. Young, R. Gearry 007 The effect of intraperitoneal placenta-derived 012 Single nucleotide polymorphisms in the control mesenchymal stem cell injection in stomachs region of mitochondrial genome are associated of diabetic mice with Irritable Bowel Syndrome: A preliminary Sung-Pyo Hong, Republic of Korea study S.-H. Lee, J.-M. Park, W.-H. Kim, K.-I. Kim, I. K. Sung Weifeng Wang, China Z. Li, X. Guo 21
ESNM 2017 Poster Presentations / Tours by Day Friday, 25 August 2017 P-07 Poster Presentation 008 Microbiota-related changes in bile acid and ser- otonin metabolism are associated with gastroin- 12:00 – 13:00 Aula Maxima testinal dysfunction in a mouse model of autism Stress and functional gastrointestinal disorders Anna Golubeva, Ireland Discussants: S. Joyce, G. Moloney, A. Burokas, A. Sherwin, S. Siobhain O’Mahony, Ireland Abstracts 001 – 006 Arboleya, K. Murphy, N. Hyland, C. Stanton, G. Serhat Bor, Turkey Abstracts 007 – 012 Clarke, C. Gahan, T. Dinan, J. Cryan Rene van den Wijngaard, 009 STW 5 prevents changes in intestinal permea- The Netherlands Abstracts 013 – 017 bility induced by psychological stress in mice Sigrid Elsenbruch, Germany Abstracts 018 – 022 Michel Neunlist, France P. Aubert, J. Chevalier, T. Durand, A. Bessard, O. 001 Handling of complex data in neurogastroenter- Kelber, H. Abdel-Aziz ology: Multi-step clustering of preclinical data for a combination phytomedicine, STW 5 010 Irritable Bowel Syndrome (IBS) and associated Olaf Kelber, Germany health problems: Insights from a primary care H. Abdel-Aziz, G. Lorkowski, K. Nieber, M. Storr registry Egbert Clevers, Sweden 002 The prevalence and impact of overlapping Rome B. Vaes, S. Henrard, G. Goderis, J. Tack, H. Törn- IV functional gastrointestinal disorders on so- blom, M. Simrén, L. van Oudenhove matisation, quality of life, and healthcare uti- lisation: Results from a three-country general 011 Irritable Bowel Syndrome (IBS) and its comor- population study bidities: What comes first? Imran Aziz, Sweden Egbert Clevers, Sweden O. Palsson, H. Tornblom, A. D. Sperber, W. White- B. Vaes, S. Henrard, G. Goderis, J. Tack, H. Törn- head, M. Simren blom, M. Simrén, L. van Oudenhove 003 The prevalence of Rome IV functional dyspepsia 012 Within-person correlations between gastrointes- and its impact on health impairment: Results tinal and psychological features of the Irritable from a three-country general population study Bowel Syndrome (IBS) Imran Aziz, Sweden Egbert Clevers, Sweden O. Palsson, H. Tornblom, A. Sperber, W. Whitehead, J. Tack, H. Törnblom, G. Ringström, L. van Ouden- M. Simren hove, M. Simrén 004 Stress differentially alters the plasma and brain 013 The effect of intragastric fructose infusion on metabolomes and caecal microbiome in Wistar homeostatic and hedonic brain regions interacts Kyoto and Sprague Dawley rats with the effect of emotional state Shalome Bassett, New Zealand Julie Iven, Belgium W. Young, K. Fraser, J. Webster, J. Dalziel, L. Ryan, J. Biesiekierski, D. Zhao, J. Tack, L. van Oudenhove J. Cryan, T. Dinan, C. Stanton, G. Clarke, N. Hyland, 014 Brain-gut miscommunication: Biopsychosocial N. Roy predictors of quality of life in IBS 005 The effect of glycoursodeoxycholic acid on epi- Goran Hauser, Croatia thelial integrity and bacterial uptake in duodenal S. Pletikosic, M. Tkalcic biopsies of patients with functional dyspepsia 015 Outcome of breath tests in adult patients with and healthy volunteers suspected small intestinal bacterial overgrowth Dorien Beeckmans, Belgium Johanna Mattsson, Sweden R. Farré, A. Keita, J. Soderhölm, J. Tack, H. Vanheel M. T. Minaya, M. Monegro, B. Lebwohl, S. Lewis, 006 Light therapy (LED 940 nm) recovers colonic P. Green, R. Stenberg motility in experimental colitis of mice 016 Cav3.2 calcium channels: Targets to relieve co- Paulo Da Silva Watanabe, United Kingdom lonic hypersensitivity encountered in Irritable R. Aktar, M. O Belém, L. A. Blackshaw, E. J.A. Araújo Bowel Syndrome (IBD) 007 Gastroesophageal reflux disease after radiofre- Elodie Picard, France quency catheter ablation of atrial fibrillation F. A. Carvalho, E. Bourinet, A. Eschalier, L. Daulhac, Mariana Floria, Romania C. Mallet O. Barboi, M. Grecu, C. Cijevschi Prelipcean, G. Balan, V.-L. Drug, V.-L. Drug 22
ESNM 2017 Poster Presentations / Tours by Day Friday, 25 August 2017 017 NUCB2/nesfatin-1 is associated with the severity 003 Effect of faecal microbiota transplantation on the of eating disorder symptoms in female obese enteroendocrine cells of the colon in patients patients with Irritable Bowel Syndrome (IBS): Double Elena Weibert, Germany blinded-placebo controlled study T. Hofmann, U. Elbelt, M. Rose, A. Stengel Magdy El-Salhy, Norway P. Holger Johnsen, T. Mazzawi, M. El-Salhy, T. 018 Antibiotic treatment prevents stress-induced Hausken, R. Goll, P. C. Valle plasticity in the PVN Agnieszka Zurek, Canada 004 Co-storage of enteroendocrine hormones eval- T.-L. Sterley, D. Baimoukhametova, J. Bains uated at the cell and subcellular levels Linda Fothergill, Australia 019 Evaluating the efficacy of mixture of boswellia car- B. Callaghan, B. Hunne, D. Bravo, J. Furness terii, zingiber officinale and achillea millefolium on severity of symptoms, anxiety and depression 005 Different proton pump inhibitors are equally in Irritable Bowel Syndrome (IBS) patients effective in inducing endoscopic and histologic Ali Toghiani, Islamic Republic of Iran remission in patients with proton pump inhibi- A. Kazemian, K. Shafiei, H. Afshar, R. Rafei, M. tor-response esophageal eosinophilia Memari, P. Adibi Edoardo Savarino, Italy S. Tolone, N. de Bortoli, O. Bartolo, V. Savarino, 020 Anhedonia is related to more severe abdominal M. della Coletta pain in Irritable Bowel Syndrome (IBS) and In- flammatory Bowel Disease (IBD) 006 Proximal esophageal baseline impedance levels Luna Carpinelli, Italy are able to discriminate between scleroderma pa- C. Bucci, A. Santonicola, F. Zingone, C. Ciacci, P. Iovino tients with and without esophageal involvement Edoardo Savarino, Italy 021 Homozygous variants in MYLK and LMOD1 P. Zentilin, E. Marabotto, S. Tolone, G. Bodini, N. cause Megacystis Microcolon Intestinal Hypop- de Bortoli, V. Savarino, M. della Coletta eristalsis Syndrome by disruption of smooth muscle contractility 007 Severe system reactions at children with intol- Robert Hofstra, The Netherlands erance to fish D. Halim, E. Brosens, M. Wangler, M. Wilson, J. Anatoly Khavkin, Russia Verheij, F. Muller, A. Burns, A. Beaudet, J. Miano, N. Esakova, E. Varlamov, A. Pampura, O. Komarova M. Alves 008 Gluten causes symptom relapse in a small group 022 Stress gone viral: Chronic social stress induces of patients with suspected non-coeliac gluten marked changes in the gut virome in mice sensitivity: A randomized, double-blind placebo Veronica Peterson, Ireland controlled challenge A. Burokas, L. Draper, M. Dalmassso, R. Cabrera-Ru- Jan Gunnar Hatlebakk, Norway bio, F. Crispie, P. Cotter, T. Dinan, C. Hill, J. Cryan N. Hovdenak, S. Otteraaen Ystad, G. Arslan Lied, H. Fjeldheim Dale 009 The influence of gluten free diet on the enteric P-08 Poster Presentation nervous system and intestinal microbiota of mice 12:00 – 13:00 Aula Maxima David Grundmann, Germany Luminal signalling/ Food allergies and intolerances V. Zevallos, S. Lehnerts, A. Braun, S. Tauchnitz, S. Discussants: Weis, M. Egert, D. Schuppan, K.-H. Schäfer Inge Depoortere, Belgium Abstracts 001 – 006 010 Low FODMAP diet improves symptoms and Catia Sternini, USA Abstracts 007 – 011 quality of life in patients with radiation-induced small bowel disease: A pilot study 001 Innervation and chemical taxonomy of gastric Trine Larsen, Norway enteroendocrine cells T. Hausken, S. Ystad, G. Lied, N. Hovdenak, B. Brid Callaghan, Australia Mueller B. Hunne, J. Fakhry, F. Linda, S. Ward, K. Sasse, 011 Peculiarities of the upper gastrointestinal tract J. Furness motility in children with atopic dermatitis 002 Abnormal stem cells and differentiation prog- Anatoly Khavkin, Russia eny into enteroendocrine cells in the colon of V. Novikova, A. Listopadova, O. Demchenkova, Y. patients with IBS Zamyatina Magdy El-Salhy, Norway T. Hausken, O. H. Gilja, J. G. Hatlebakk 23
ESNM 2017 Poster Presentations / Tours by Day Friday, 25 August 2017 P-09 Poster Presentation 010 Chronic gut leakiness induces gender-specific neurobehavioral alterations in transgenic CA- 12:00 – 13:00 Aula Maxima MLCK mice Mixed topics Marion Rincel, France Discussants: L. Xia, C. Monchaux de Oliveira, J. Thomas, V. Bac- David Grundy, United Kingdom Abstracts 001 – 005 quie, L. Gros, A. Dinca, S. Barnett Burns, Y. Matime, André Smout, The Netherlands Abstracts 006 – 010 J. Turner, L. Capuron, V. Théodorou, L. Ferrier, M. Adam Farmer, United Kingdom Abstracts 011 – 015 Darnaudéry Ihsan Ekin Demir, Germany Abstracts 016 – 021 011 Wireless optogenetics: Development of simul- taneous activation of multiple light emitting 001 Cost effective of IBDoc as a surrogate marker of mucosal healing in IBD patients post induction diodes (green and blue) for activation or inhi- of biological agents bition of multiple different neural pathways Gafer Elsafi, Ireland Nick Spencer, Australia L. Barry, K. Sugrue, M. Farman, D. Fitzgerald, A. 012 Influence of dimethyl fumarate on murine post- Alhanaee, M. Buckley, J. McMarthy operative ileus 002 Acute tryptophan depletion increases esopha- Jonas van Dingenen, Belgium geal sensitivity to acid perfusion in health R. A. Lefebvre Charlotte Broers, Belgium 013 Investigation to prevent postoperative ileus via B. van Houtte, P. Vermeersch, N. Peersman, J. Tack, A. Pauwels peroral CO Jonas van Dingenen, Belgium 003 Effect of faecal microbiota transplantation on C. Steiger, M. Zehe, L. Meinel, R. A. Lefebvre the symptoms and gut microbiota in patients with Irritable Bowel Syndrome (IBS) 014 Innervation pattern of the distal mucosal squa- Trygve Hausken, Norway mous epithelium may underlie hyposensitivity to T. Mazzawi, G. Arslan Lied, D. A. Sangnes, J. E. acid reflux in patients with Barrett‘s oesophagus Roksund Hov, O. H. Gilja, J. G. Hatlebakk, M. El-Salhy Philip Woodland, United Kingdom F. Grassi, J. Evans, S. McDonald, M. Peiris, R. Aktar, 004 The levels of pantoprazole in human breast milk and plasma: Two compartment model J. Ooi, C. Lee, L. A. Blackshaw, D. Sifrim Pelin Ergun, Turkey 015 Melanin-concentrating hormone receptor 1 ex- S. Bor, S. Karacaoglu, S. Kipcak, G. Turkyilmaz, pression in colon: A multiplex immunohistochem- E. Karasulu ical study with colon from „normal“ donors and 005 Validation of the Korean version of the GerdQ patients with Inflammatory Bowel Disease (IBD) questionnaire for diagnosis of gastro-esophageal Nicholas Barnes, United Kingdom reflux disease S. Yusoff, G. Grafton, T. Pinkney Kee-Wook Jung, Republic of Korea 016 Tickling the 5-HT3 receptor: Potential therapeu- Y.-W. Min, K.-S. Hong, H.-J. Son, O.-Y. Lee tic opportunities for patients with diarrhea-pre- 006 Pathogenic mechanisms of esophageal peristaltic dominant Irritable Bowel Syndrome (IBS) from dysfunction by high resolution manometry in the selective 5-HT3 receptor partial agonist, patients with systemic sclerosis CSTI-300 Joon-Seong Lee, Republic of Korea Nicholas Barnes, United Kingdom 007 Anti-inflammatory mechanisms of action in FD A. Roberts, G. Grafton, Y. Mo, D. Meng, D. Xie, S. and IBS: The example of STW 5 Liu, P. Guzzo Olaf Kelber, Germany 017 Radiocontrast media guided interpretation for K. Nieber lactulose hydrogen breath test 008 Inflammatory conditions favor the interactions Jong-Sun Rew, Republic of Korea between T cells and enteric glial cells S.-Y. Park, S.-W. Park, S.-W. Park, J.-H. Seo, E.-A. Julie Pabois, France Cho, C.-H. Park, H.-S. Kim T. Durand, J. A. Gonzales, M. Neunlist, I. Neveu, P. Naveilhan 018 NDRG4 is an enteric neuronal protein which attenuates intestinal tumor progression and 009 Parasympathomimetic agents inhibit pancreatic protects against colitis-induced injury cancer growth by suppression of the p44/42 MAPK Nathalie Vaes, The Netherlands signalling pathway and increase overall survival V. Melotte, G. Rademakers, M. J. Gijbels, K. L. Dae- Paulo Leonardo Pfitzinger, Germany I. E. Demir, E. Tieftrunk, K. Wang, H. Friess, G. nen, K. A. D. Wouters, R. M. W. Hofstra, M. van O. Ceyhan Engeland 24
You can also read